Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways
Authors
Keywords
-
Journal
Metallomics
Volume 7, Issue 3, Pages 439-447
Publisher
Royal Society of Chemistry (RSC)
Online
2015-01-23
DOI
10.1039/c4mt00312h
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Binuclear Gold(I) Complex with Mixed Bridging Diphosphine and Bis(N-Heterocyclic Carbene) Ligands Shows Favorable Thiol Reactivity and Inhibits Tumor Growth and Angiogenesis In Vivo
- (2014) Taotao Zou et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling
- (2014) Zhennan Zhao et al. DALTON TRANSACTIONS
- Synthesis of 2-Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid-β Aggregation and Neurotoxicity Evaluation
- (2014) Gorakh S. Yellol et al. INORGANIC CHEMISTRY
- Discovery of a Highly Tumor-Selective Organometallic Ruthenium(II)–Arene Complex
- (2014) Catherine M. Clavel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase
- (2014) Zuandi Luo et al. Metallomics
- On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexes
- (2013) Gorakh S. Yellol et al. CHEMICAL COMMUNICATIONS
- Microwave-assisted synthesis of arene ruthenium(II) complexes that induce S-phase arrest in cancer cells by DNA damage-mediated p53 phosphorylation
- (2013) Qiong Wu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway
- (2013) Cundong Fan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Synthesis, Structural Characterization, and Photophysical, Spectroelectrochemical, and Anion-Sensing Studies of Heteroleptic Ruthenium(II) Complexes Derived from 4′-Polyaromatic-Substituted Terpyridine Derivatives and 2,6-Bis(benzimidazol-2-yl)pyridine
- (2013) Dinesh Maity et al. INORGANIC CHEMISTRY
- Interaction between 8-hydroxyquinoline ruthenium(ii) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways
- (2013) Licong Yang et al. Metallomics
- On the Biological Properties of Alkynyl Phosphine Gold(I) Complexes
- (2012) Andreas Meyer et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation
- (2012) Linlin Li et al. DALTON TRANSACTIONS
- Molecular and Cellular Characterization of the Biological Effects of Ruthenium(II) Complexes Incorporating 2-Pyridyl-2-pyrimidine-4-carboxylic Acid
- (2012) Vanessa Pierroz et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Enhancement of cell permeabilization apoptosis-inducing activity of selenium nanoparticles by ATP surface decoration
- (2012) Yibo Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480
- (2011) H. Xin et al. CANCER RESEARCH
- Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers
- (2011) Linlin Li et al. DALTON TRANSACTIONS
- Synthesis, Structural Characterization, Photophysical, Electrochemical, and Anion-Sensing Studies of Luminescent Homo- and Heteroleptic Ruthenium(II) and Osmium(II) Complexes Based on Terpyridyl-imidazole Ligand
- (2011) Chanchal Bhaumik et al. INORGANIC CHEMISTRY
- P-donor ligand containing ruthenium half-sandwich complexes as protein kinase inhibitors
- (2011) Craig Streu et al. INORGANICA CHIMICA ACTA
- Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Vascular endothelial growth factors and receptors: Anti-angiogenic therapy in the treatment of cancer
- (2011) Sònia Tugues et al. MOLECULAR ASPECTS OF MEDICINE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Tumor angiogenesis: molecular pathways and therapeutic targets
- (2011) Sara M Weis et al. NATURE MEDICINE
- Characterization of a Ruthenium(III)/NAMI-A Adduct with Bovine Serum Albumin that Exhibits a High Anti-Metastatic Activity
- (2010) Mimi Liu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Fascinating variability in the chemistry and properties of 2,6-bis-(benzimidazol-2-yl)-pyridine and 2,6-bis-(benzthiazol-2-yl)-pyridine and their complexes
- (2010) Miroslav Boča et al. COORDINATION CHEMISTRY REVIEWS
- Synthesis, Characterization, Photophysical, and Anion-Binding Studies of Luminescent Heteroleptic Bis-Tridentate Ruthenium(II) Complexes Based on 2,6-Bis(Benzimidazole-2-yl)Pyridine and 4′-Substituted 2,2′:6′,2′′ Terpyridine Derivatives
- (2010) Chanchal Bhaumik et al. INORGANIC CHEMISTRY
- Ruthenium Polypyridyl Complexes That Induce Mitochondria-Mediated Apoptosis in Cancer Cells
- (2010) Tianfeng Chen et al. INORGANIC CHEMISTRY
- Modulation of the Biological Properties of Aspirin by Formation of a Bioorganometallic Derivative
- (2009) Ingo Ott et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Kisspeptin-10, a KISS1-Derived Decapeptide, Inhibits Tumor Angiogenesis by Suppressing Sp1-Mediated VEGF Expression and FAK/Rho GTPase Activation
- (2009) S.-G. Cho et al. CANCER RESEARCH
- Morelloflavone, a Biflavonoid, Inhibits Tumor Angiogenesis by Targeting Rho GTPases and Extracellular Signal-Regulated Kinase Signaling Pathways
- (2009) X. Pang et al. CANCER RESEARCH
- EPOX Inhibits Angiogenesis by Degradation of Mcl-1 through ERK Inactivation
- (2009) H.-L. Sun et al. CLINICAL CANCER RESEARCH
- Naphthalimide gold(i) phosphine complexes as anticancer metallodrugs
- (2009) Christoph P. Bagowski et al. DALTON TRANSACTIONS
- A Gold(I) Phosphine Complex Containing a Naphthalimide Ligand Functions as a TrxR Inhibiting Antiproliferative Agent and Angiogenesis Inhibitor
- (2009) Ingo Ott et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antiangiogenic strategies for treatment of malignant gliomas
- (2009) Andrew S. Chi et al. Neurotherapeutics
- Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy
- (2008) Masuko Ushio-Fukai et al. CANCER LETTERS
- Caspase- and p53-dependent apoptosis in breast carcinoma cells induced by a synthetic selenadiazole derivative
- (2008) Tianfeng Chen et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search